NeoGenomics names Warren Stone, its current president and COO, as incoming CEO, effective Jan. 4, 2027. Current CEO Tony Zook will shift to executive chairman the same day. The move follows years of internal planning, the company says, and emphasizes continuity in strategy. Stone joined NeoGenomics in 2022 and has held leadership roles including president of clinical services. Zook says the two will work closely through the transition and continue collaborating afterward.
This article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.